Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

OrganOx

Health Tech & Medtech · Oxford, United Kingdom · Founded 2008 Unicorn

Normothermic organ perfusion system for liver transplantation

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Revenue
$50–100M
Latest reported FY
Unlock exact value
Headcount
100–500
Current team size
Unlock exact value

Investors

16 investors on OrganOx's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
Oxford Technology
Adam Niewinski
Technikos
Series B+ 13 investors entered at this stage
Piper Heartland Healthcare Capital
Intuitive Ventures
Royal Society Enterprise Fund
Longwall Ventures
University of Oxford
Business Growth Fund
Oxford University Innovation
Avidity Partners
Soleus Capital
HealthQuest Capital
Sofina
Lauxera Capital Partners
Terumo Corporation

Global footprint

Where OrganOx has talent and traffic

AI talent share
0.5% of workforce is AI talent
(1 of 216 staff)
Core AI10.46%
Other AI00%
Non-AI workforce21599.54%
Workforce by country
5 countries with
team presence
🇬🇧 United Kingdom53.2%
🇺🇸 United States44%
🇩🇪 Germany1.3%
🇫🇷 France1%
🇨🇭 Switzerland0.6%
5 countries shown
Web traffic by country
9.6K monthly visits
across markets
🇺🇸 United States51%
🇬🇧 United Kingdom30.2%
🇮🇳 India19.8%
Top 3 markets shown

Market sentiment

What the market is saying about OrganOx

An AI-synthesized read of the highest-engagement posts about OrganOx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See OrganOx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.